Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 22
Filter
2.
JACC Clin Electrophysiol ; 10(5): 857-866, 2024 May.
Article in English | MEDLINE | ID: mdl-38456860

ABSTRACT

BACKGROUND: Tetralogy of Fallot (TOF) is associated with risk for sustained monomorphic ventricular tachycardia (VT). Preemptive electrophysiology study before transcatheter pulmonary valve placement is increasing, but the value of MDCT for anatomical VT isthmus assessment is unknown. OBJECTIVES: The purpose of this study was to determine the impact of multidetector computed tomography (MDCT) in the evaluation of sustained monomorphic VT for repaired TOF. METHODS: Consecutive pre-transcatheter pulmonary valve MDCT studies were identified, and anatomical isthmus dimensions were measured. For a subset of patients with preemptive electrophysiology study, MDCT features were compared with electroanatomical maps. RESULTS: A total of 61 repaired TOFs with MDCT were identified (mean 35 ± 14 years, 58% men) with MDCT electroanatomical map pairs in 35 (57%). Calcification corresponding to patch material was present in 46 (75%) and was used to measure anatomical VT isthmuses. MDCT wall thickness correlated positively with number of ablation lesions and varied with functional isthmus properties (blocked isthmus 2.6 mm [Q1, Q3: 2.1, 4.0 mm], slow conduction 4.8 mm [Q1, Q3: 3.3, 6.0 mm], and normal conduction 5.6 mm [Q1, Q3: 3.9, 8.3 mm]; P < 0.001). A large conal branch was present in 6 (10%) and a major coronary anomaly was discovered in 3 (5%). Median ablation lesion distance was closer to the right vs the left coronary artery (10 mm vs 15 mm; P = 0.01) with lesion-to-coronary distance <5 mm in 3 patients. CONCLUSIONS: MDCT identifies anatomical structures relevant to catheter ablation for repaired TOF. Wall thickness at commonly targeted anatomical VT isthmuses is associated with functional isthmus properties and increased thermal energy delivery.


Subject(s)
Multidetector Computed Tomography , Tachycardia, Ventricular , Tetralogy of Fallot , Humans , Tachycardia, Ventricular/physiopathology , Tachycardia, Ventricular/diagnostic imaging , Tachycardia, Ventricular/surgery , Tetralogy of Fallot/surgery , Tetralogy of Fallot/diagnostic imaging , Tetralogy of Fallot/physiopathology , Male , Female , Adult , Middle Aged , Young Adult , Catheter Ablation
3.
Front Cardiovasc Med ; 10: 1107399, 2023.
Article in English | MEDLINE | ID: mdl-37469486

ABSTRACT

The ferumoxytol-enhanced 4D MR angiography with MUSIC (Multiphase Steady State Imaging with Contrast) technique provides a single data set that captures dynamic cardiovascular anatomy and ventricular function at the same time. Homogeneous opacification of all cardiovascular structures within the imaging volume allows full sequential segmental approach to the congenital heart diseases without any blind spots. The complex systemic and pulmonary venous anatomy is particularly well captured in the MUSIC. Cinematographic display of multiplanar sectional and 3D volume images is helpful in the morphological identification of the cardiac chambers, the assessment of the dynamic nature of the ventricular outflow tracts, and the assessment of the coronary arterial origins and courses.

4.
J Am Soc Echocardiogr ; 36(2): 233-241, 2023 02.
Article in English | MEDLINE | ID: mdl-36228840

ABSTRACT

BACKGROUND: Venoarterial extracorporeal membrane oxygenation (ECMO) supports patients with advanced cardiac dysfunction; however, mortality occurs in a significant subset of patients. The authors performed a multicenter, prospective study to determine hemodynamic and echocardiographic predictors of mortality in children placed on ECMO for cardiac support. METHODS: Over 8 years, six heart centers prospectively assessed echocardiographic and hemodynamic variables on full and minimum ECMO flow. Sixty-three patients were enrolled, ranging in age from 1 day to 16 years. Hemodynamic measurements included heart rate, vasoactive inotropic score, arteriovenous oxygen difference, pulse pressure, and lactate. Echocardiographic variables included shortening fraction, ejection fraction (EF), right ventricular fractional area change, outflow tract Doppler-derived stroke distance (velocity-time integral [VTI]), and degree of atrioventricular valve regurgitation. Patients were stratified into two groups: those who were able to wean within 48 hours of assessment and survived without ventricular assist devices or orthotopic heart transplantation (successful wean group) and those with unsuccessful weaning. For each patient, variables were compared between full and minimum ECMO flow for each group. RESULTS: Thirty-eight patients (60%) formed the unsuccessful group (two with ventricular assist devices, four with orthotopic heart transplantation, 24 deaths), and 25 constituted the successful wean group. At minimum flow, higher EF (53 ± 16% vs 40 ± 20%, P = .0094), less mitral regurgitation (0.8 ± 0.9 vs 1.4 ± 0.9, P = .0329), and lower central venous pressure (12.0 ± 3.9 vs 14.7 ± 5.4 mm Hg), along with higher VTI (9.0 ± 2.9 vs 6.8 ± 3.7 cm, P = .0154), correlated successful weaning. A longer duration of ECMO (8 vs 5 days, P < .0002) was associated with unsuccessful weaning. Multivariate logistic regression predicted minimum-flow EF and VTI to independently predict successful weaning with cutoff values by receiver operating characteristic analysis of EF > 41% (area under the curve, 0.712; P = .0005) and VTI > 7.9 cm (area under the curve, 0.729; P = .0010). CONCLUSIONS: Diminished VTI or EF during ECMO weaning predicts the need for orthotopic heart transplantation or ventricular assist device support or death in children on ECMO for cardiac dysfunction. Increased postwean central venous pressure or mitral regurgitation along with a prolonged ECMO course also predicted these adverse outcomes. These measurements should be used to help discriminate which patients will require alternative methods of circulatory support for survival.


Subject(s)
Extracorporeal Membrane Oxygenation , Mitral Valve Insufficiency , Humans , Child , Extracorporeal Membrane Oxygenation/methods , Prospective Studies , Echocardiography , Hemodynamics , Retrospective Studies
5.
Catheter Cardiovasc Interv ; 100(3): 399-403, 2022 09.
Article in English | MEDLINE | ID: mdl-35819275

ABSTRACT

Transcatheter correction of a superior sinus venosus defect and partial anomalous pulmonary venous connection with covered stents is a feasible alternative to surgical repair in select patients. Commercially available balloon-expandable covered stents may be of inadequate length to treat some patients. This may require multiple stents to be placed, which increases the risk of stent migration or embolization. A modification of this technique utilizing two interdigitating covered stents secured together with sutures is described, allowing for increased stability of a long stent complex. One failed case and a second successful case are presented.


Subject(s)
Heart Septal Defects, Atrial , Pulmonary Veins , Heart Septal Defects, Atrial/surgery , Heart Septal Defects, Atrial/therapy , Humans , Pulmonary Veins/abnormalities , Pulmonary Veins/diagnostic imaging , Pulmonary Veins/surgery , Stents , Sutures , Treatment Outcome
7.
Catheter Cardiovasc Interv ; 97(4): E514-E517, 2021 03.
Article in English | MEDLINE | ID: mdl-33197132

ABSTRACT

Transcatheter closure of large apical muscular ventricular septal defects (VSDs) can be performed via transfemoral or hybrid approach. A very large apical muscular VSD was closed via a hybrid approach. A strategy for deployment of a right ventricular stay suture was utilized to minimize the risk of device embolization without the use of bypass and without externalization of a portion of the device.


Subject(s)
Heart Septal Defects, Ventricular , Cardiac Catheterization/adverse effects , Heart Septal Defects, Ventricular/diagnostic imaging , Heart Septal Defects, Ventricular/surgery , Heart Ventricles , Humans , Sutures , Treatment Outcome
8.
World J Pediatr Congenit Heart Surg ; 11(6): 797-801, 2020 Nov.
Article in English | MEDLINE | ID: mdl-33164685

ABSTRACT

BACKGROUND: Three-dimensional printing is increasingly recognized as a valuable tool for congenital heart disease (CHD) procedural planning and education. Cost and complexity currently limit the more widespread adoption of this technology. We sought to demonstrate the accuracy of 3D printed CHD models created from contrast-enhanced magnetic resonance imaging (MRI) and computed tomography (CT) scans using free software and an inexpensive desktop fused filament fabrication (FFF) printer. METHODS: Solid segmentations of the intracardiac blood pool were created with the program ITK-SNAP. Using the computer program Meshmixer, the segmentation model was hollowed to create a 0.8 mm shell with the inner surface representing endocardium. Three-dimensional models were created on an FFF printer. Four arteries and a ventricular septal defect (VSD) were 3D printed and measured for accuracy. Five models were used to assess candidacy for biventricular surgical repair and one to guide an interventional catheterization. RESULTS: All six patients underwent intervention planned with the 3D models. The computer model shell walls all achieved specifications within 0.05 mm of the designated 0.8 mm thickness and the original solid blood pool segmentation fit within the hollowed 3D model. The 3D printed arteries and VSD all measured accurately to within 0.5 mm of their source computer model. CONCLUSION: Accurate 3D printed models of complex, pediatric CHD may be created from volumetric MRI and CT studies using free online software and printed on an inexpensive desktop printer.


Subject(s)
Computer Simulation , Heart Defects, Congenital/diagnosis , Imaging, Three-Dimensional/methods , Magnetic Resonance Imaging, Cine/methods , Models, Anatomic , Printing, Three-Dimensional , Tomography, X-Ray Computed/methods , Humans , Reproducibility of Results , Software
9.
Heart Rhythm ; 17(10): 1752-1758, 2020 10.
Article in English | MEDLINE | ID: mdl-32438019

ABSTRACT

BACKGROUND: Although they are at lower risk, patients with previous extracardiac conduit (EC) Fontan still may require catheter ablation for supraventricular arrhythmia. OBJECTIVE: The purpose of this study was to determine the optimal approach to pulmonary venous atrium (PVA) access after EC Fontan operation. METHODS: All electrophysiological procedures requiring PVA over a 10-year period at the UCLA Medical Center were reviewed. PVA was grouped by transcaval cardiac puncture (TCP) or direct conduit puncture. Procedural characteristics and outcomes were compared. RESULTS: Between June 2009 and November 2019, 23 electrophysiological procedures requiring PVA access were performed in 17 EC Fontan patients (53% male; median age 25 years; interquartile range 11-34). Cavoatrial overlap was identified in 14 patients by preprocedural imaging (10 cardiac computed tomography, 4 cardiac magnetic resonance). PVA access was obtained via TCP in 11, direct conduit puncture in 6, pre-existing fenestration in 5, and pulmonary artery puncture in 1. Time to PVA was significantly shorter for TCP vs direct conduit puncture (0.2 vs 1.1 hours, respectively; P = .03). The only predictor of successful TCP was the length of cavoatrial overlap by preprocedural imaging (14 vs 3 mm; P = .02). No procedural complications occurred. No change in oxygen saturation was noted, and no evidence of residual shunting was detected by follow-up echocardiography. CONCLUSION: TCP is feasible in most patients after EC Fontan surgery and can be predicted by preprocedural advanced imaging. TCP is associated with shorter time to PVA and was uncomplicated in this single-center study. Preoperative assessment of cavoatrial overlap should be considered before catheter ablation for EC Fontan.


Subject(s)
Arrhythmias, Cardiac/surgery , Catheter Ablation/methods , Fontan Procedure , Forecasting , Heart Defects, Congenital/surgery , Pulmonary Veins/surgery , Adolescent , Adult , Arrhythmias, Cardiac/complications , Arrhythmias, Cardiac/physiopathology , Child , Echocardiography , Female , Follow-Up Studies , Heart Atria , Heart Defects, Congenital/complications , Heart Defects, Congenital/diagnosis , Humans , Male , Retrospective Studies , Treatment Outcome , Venae Cavae , Young Adult
10.
Transplantation ; 102(10): e431-e438, 2018 10.
Article in English | MEDLINE | ID: mdl-29916988

ABSTRACT

BACKGROUND: Donor-specific HLA antibodies (DSA) are associated with increased rates of rejection and of graft failure in cardiac transplantation. The goal of this study was to determine the association of preformed and posttransplant development of newly detected DSA (ndDSA) with antibody-mediated rejection (AMR) and characterize the clinical relevance of complement-activating DSA in heart allograft recipients. METHODS: The study included 128 adult and 48 pediatric heart transplant patients transplanted between 2010 and 2013. Routine posttransplant HLA antibody testing was performed by IgG single-antigen bead test. The C3d single-antigen bead assay was used to identify complement-activating antibodies. Rejection was diagnosed using International Society for Heart and Lung Transplantation criteria. RESULTS: In this study, 22 patients were transplanted with preexisting DSA, and 43 patients developed ndDSA posttransplant. Pretransplant (P < 0.05) and posttransplant (P < 0.001) ndDSA were associated with higher incidence of AMR. Patients with C3d + DSA had significantly higher incidence of AMR compared with patients with no DSA (P < 0.001) or patients with C3d-DSA (P = 0.02). Nine (36%) of 25 patients with AMR developed transplant coronary artery disease compared with 17 (15.9%) of 107 patients without AMR (P < 0.05). Among the 47 patients who received ventricular assistant device (VAD), 7 of 9 VAD+ patients with preformed DSA experienced AMR compared with 7 of 38 VAD+ patients without preformed DSA, indicating presensitization to donor HLA significantly increased the risk of AMR (P < 0.01). CONCLUSIONS: Preformed and posttransplant ndDSA were associated with AMR. C3d + DSA correlates with complement deposition on the graft and higher risk of AMR which may permit the application of personalized immunotherapy targeting the complement pathway.


Subject(s)
Complement Activation/immunology , Graft Rejection/immunology , HLA Antigens/immunology , Heart Diseases/surgery , Heart Transplantation/adverse effects , Isoantibodies/blood , Adolescent , Adult , Child , Child, Preschool , Complement C3d/analysis , Complement C3d/immunology , Female , Graft Rejection/blood , Graft Rejection/epidemiology , Graft Rejection/prevention & control , Graft Survival/immunology , Heart Diseases/mortality , Heart-Assist Devices , Histocompatibility Testing/methods , Humans , Incidence , Infant , Isoantibodies/immunology , Kaplan-Meier Estimate , Male , Middle Aged , Tissue Donors , Treatment Outcome , Young Adult
11.
Pediatr Dev Pathol ; 18(1): 71-5, 2015.
Article in English | MEDLINE | ID: mdl-25386687

ABSTRACT

Diabetic embryopathy refers to a constellation of congenital malformations arising in the setting of poorly controlled maternal diabetes mellitus. Cardiac abnormalities are the most frequently observed findings, with a 5-fold risk over normal pregnancies. Although a diverse spectrum of cardiac defects has been documented, cardiac noncompaction morphology has not been associated with this syndrome. In this report, we describe a novel case of biventricular cardiac noncompaction in a neonate of a diabetic mother. The patient was a late preterm female with right anotia, caudal dysgenesis, multiple cardiac septal and aortic arch defects, and biventricular cardiac noncompaction. Examination of both ventricles demonstrated spongy myocardium with increased myocardial trabeculation greater than 50% left ventricular thickness and greater than 75% right ventricular thickness, with hypoplasia of the bilateral papillary muscles, consistent with noncompaction morphology. Review of the literature highlights the importance of gene expression and epigenomic regulation in cardiac embryogenesis.


Subject(s)
Abnormalities, Multiple/diagnosis , Heart Diseases/diagnosis , Diabetes Complications , Echocardiography/methods , Fatal Outcome , Female , Fetal Diseases/pathology , Heart/embryology , Heart Defects, Congenital , Heart Diseases/congenital , Heart Ventricles/embryology , Heart Ventricles/pathology , Humans , Myocardium/pathology , Pregnancy , Pregnancy Complications , Pregnancy in Diabetics
12.
Cardiovasc Pathol ; 23(6): 381-2, 2014.
Article in English | MEDLINE | ID: mdl-25108499

ABSTRACT

Posterolateral hypertrophic cardiomyopathy (HCM) is a rare variant of HCM. Segmental HCM is seen in 12% of cases of HCM. Among the patterns of segmental HCM, posterolateral HCM is the least common type. Our case of an 18-year old male documents this unusual type of cardiomyopathy. In this form of HCM, left ventricular thickness and the extent of hypertrophy might be underestimated by 2-dimensional echocardiography. This case illustrates the echocardiographic and pathologic features of posterolateral HCM.


Subject(s)
Cardiomyopathy, Hypertrophic/pathology , Adolescent , Cardiomyopathy, Hypertrophic/diagnostic imaging , Cardiomyopathy, Hypertrophic/surgery , Echocardiography , Heart Transplantation , Heart Ventricles/diagnostic imaging , Heart Ventricles/pathology , Humans , Male , Myocytes, Cardiac/pathology
13.
Am J Med Genet A ; 161A(7): 1773-8, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23696469

ABSTRACT

Deletions of the long arm of chromosome 18 have been previously reported in many patients. Most cases involve the more distal regions of the long arm (18q21.1->qter). However, proximal interstitial deletions involving 18q11.2 are extremely rare. Here we report on a 14-month-old female with a 4.7 Mb (19,667,062-24,401,876 hg19) de novo interstitial deletion within chromosomal band 18q11.2, which includes GATA6 and 24 other RefSeq genes. The clinical features of our patient include complex congenital heart defects, a double outlet right ventricle, a subaortic ventricular septal defect, D-malposed great arteries, an atrial septal defect, a dysplastic aortic valve and patent ductus arteriosus. In addition, she had renal anomalies-a duplicated collecting system on the left and mild right hydronephrosis. These heart and renal defects are not reported in other patients with 18q proximal interstitial deletions. Heterozygous point mutations in GATA6, encoding for a zinc finger transcription factor, have been shown to cause congenital heart defects. Given the well-established biological role of GATA6 in cardiac development, a deletion of GATA6 is very likely responsible for our patient's complex congenital heart defects. This is the smallest and most proximal 18q11.2 deletion involving GATA6 that is associated with complex congenital heart disease and renal anomalies.


Subject(s)
Chromosome Disorders/genetics , Heart Defects, Congenital/genetics , Kidney/abnormalities , Chromosome Deletion , Chromosome Disorders/etiology , Chromosomes, Human, Pair 18/genetics , Female , GATA6 Transcription Factor/genetics , Humans , Infant , Infant, Newborn , Pregnancy
14.
Cardiovasc Pathol ; 22(5): 345-50, 2013.
Article in English | MEDLINE | ID: mdl-23518027

ABSTRACT

BACKGROUND: Endocardial fibroelastosis (EFE) is a thickening of the endocardium by collagen and elastic fibers. Primary EFE is characterized by a dilated left ventricle (LV) that typically has a high takeoff of the papillary muscles and thickening of the free edge of the mitral valve leaflets, in addition to diffuse thickening of the endocardium by aortic-like thick and parallel elastic fibers. In the past, EFE was considered a rare cardiomyopathy, but in the latest American Heart Association classification (2006) of cardiomyopathies, EFE is not mentioned. The existence of the entity of "primary" EFE has been questioned. METHODS: We reviewed medical records, echocardiograms, explanted hearts, and microscopic slides from 52 pediatric heart transplant cases at our institution with a diagnosis of dilated cardiomyopathy (DCM). RESULTS: Fourteen hearts showed both gross and microscopic findings of primary EFE, with no apparent cause of the diffuse endocardial thickening. Patients with EFE were significantly younger than patients with DCM (median age: 10.1 vs. 142.0 months). No case of EFE was diagnosed clinically. LV wall and endocardial thickness were significantly greater in EFE, with the mitral valve and papillary muscles showing characteristic findings. CONCLUSIONS: Clinically and pathologically, EFE is different from DCM. EFE is not rare and found in 25% of pediatric cases transplanted for "DCM." EFE should be recognized to promote understanding of the natural history and etiology of EFE.


Subject(s)
Cardiomyopathy, Dilated/diagnosis , Endocardial Fibroelastosis/diagnosis , Adolescent , Cardiomyopathy, Dilated/pathology , Cardiomyopathy, Dilated/physiopathology , Child , Child, Preschool , Diagnosis, Differential , Echocardiography , Endocardial Fibroelastosis/pathology , Endocardial Fibroelastosis/physiopathology , Female , Heart Transplantation , Hemodynamics , Humans , Infant , Male , Retrospective Studies
15.
Cardiovasc Pathol ; 22(1): 54-7, 2013.
Article in English | MEDLINE | ID: mdl-22475572

ABSTRACT

BACKGROUND: Failed pediatric heart allografts with diastolic dysfunction exhibit severe epicardial fibrosis. The molecular mechanism underlying this process is poorly understood. Canonical Wnt/ß-catenin signaling plays an important role in epithelial-mesenchymal transition and is implicated in fibrosing diseases. In this study, we tested the hypothesis that canonical Wnt/ß-catenin signaling is activated in epicardial fibrosis of end-stage dysfunctional pediatric allografts. METHODS: Fourteen explanted heart grafts of 12 patients who had undergone 14 heart transplantations were used for immunohistochemical staining of ß-catenin and its nuclear binding partners, T-cell factor/lymphoid enhancer factor family transcriptional factors. Fourteen age-matched native hearts from patients who had undergone first heart transplantation without evidence of epicardial fibrosis were used as controls. RESULTS AND CONCLUSIONS: Epicardial fibroblasts from explanted allografts demonstrated nuclear accumulation of ß-catenin. These cells also showed nuclear positivity for T-cell factor 4. No T-cell factor 3 expression was present in the epicardium. T-cell factor 1 and lymphoid enhancer factor 1 were observed in lymphocytes, but not in other cell types of the epicardium. These findings suggest an association between canonical Wnt/beta-catenin signaling and epicardial fibrosis of failed pediatric heart allografts. Should activation of this pathway be shown to be causal to epicardial fibrosis in this setting, then inhibition of this pathway may help to prevent this devastating process.


Subject(s)
Heart Transplantation/adverse effects , Pericardium/chemistry , Ventricular Dysfunction/metabolism , Ventricular Function , Wnt Signaling Pathway , beta Catenin/analysis , Case-Control Studies , Diastole , Fibroblasts/chemistry , Fibroblasts/pathology , Fibrosis , Humans , Immunohistochemistry , Pericardium/pathology , Transcription Factor 7-Like 2 Protein/analysis , Treatment Failure , Ventricular Dysfunction/etiology , Ventricular Dysfunction/pathology
16.
J Heart Lung Transplant ; 30(9): 1044-50, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21640617

ABSTRACT

BACKGROUND: Cardiac allograft vasculopathy (CAV) is a major limitation to the long-term success of cardiac transplantation. Although there are published descriptions of the lesions, there have been no studies delineating the pathology of CAV in a large series of patients who underwent retransplantation for CAV. METHODS: We reviewed archival records and microscopic sections of surgically explanted hearts from 64 patients who underwent cardiac retransplantation: 54 adults (18 to 70 years old) and 10 children (3 to 15 years old). Vascular lesions were categorized as showing intimal fibromuscular hyperplasia, atherosclerosis and/or inflammation. The degree of luminal narrowing was estimated from gross descriptions and microscopic sections. RESULTS: In total, 75% of hearts had evidence of acute cellular rejection, mostly mild. Intramyocardial arteries showed primarily intimal fibromuscular hyperplasia and inflammation with no atheromas present. Large and branch epicardial coronary arteries were narrowed in at least one artery of all hearts. Lesions in the epicardial coronary arteries were composed of intimal fibromuscular hyperplasia, atherosclerosis and/or inflammation affecting one or more vascular layers (intima, media and adventitia). Severe CAV with >75% luminal narrowing was seen in the LAD in 17% of hearts, the LCx in 17% and the RCA in 22% of hearts. Two hearts had severe narrowing of the left main coronary artery. Nineteen arteries had luminal thrombi. All hearts had narrowing of smaller epicardial branch coronary arteries that was often severe. Atheromas were present in arteries of adults and children; thus, not all atheromas could be considered pre-existing prior to transplantation. Both arteries and veins showed intimal hyperplasia and inflammation. CONCLUSIONS: CAV is a pathologically multifaceted disorder that affects large and small epicardial coronary arteries of adults and children, with different types of lesions: intimal fibromuscular hyperplasia; atherosclerosis; and/or inflammation (vasculitis). Therapies to address this disease must take into account the protean nature of the vascular lesions.


Subject(s)
Coronary Disease/pathology , Coronary Vessels/pathology , Heart Transplantation/pathology , Myocardium/pathology , Adolescent , Adult , Aged , Child , Child, Preschool , Coronary Artery Disease/pathology , Coronary Disease/complications , Female , Graft Rejection/etiology , Humans , Hyperplasia/pathology , Male , Middle Aged , Retrospective Studies , Transplantation, Homologous , Tunica Intima/pathology , Vasculitis/pathology , Young Adult
17.
J Transplant ; 2010: 656984, 2010.
Article in English | MEDLINE | ID: mdl-20224752

ABSTRACT

Background. Although pulmonary hypertension complicating dilated cardiomyopathy has been shown to be a significant risk factor for graft failure after heart transplantation, the upper limits of pulmonary vascular resistance (PVR) that would contraindicate pediatric heart transplantation are not known. Methods. A retrospective review of all pediatric orthotopic heart transplant (OHT) performed at our institution from 2002 to 2007 was performed. Seven patients with PVR > 6 Wood's units (WU) prior to transplant were compared pre- and postoperatively with 20 matched controls with PVR < 6 WU. All pulmonary vasodilator therapies used are described as well as outcomes during the first year posttransplant. Results. The mean PVR prior to transplantation in the 7 study cases was 11.0 +/- 4.6 (range 6-22) WU, compared to mean PVR of 3.07 +/- 0.9 WU (0.56-4.5) in the controls (P = .27 x 10(-6)). All patients with elevated PVR were treated pre-OHT with either Sildenafil or Bosentan. Post-OHT, case patients received a combination of sildenafil, iloprost, and inhaled nitric oxide. All 7 case patients survived one year post-OHT, and there was no statistical difference between cases and controls for hospital stay, rejection/readmissions, or graft right ventricular failure. Mean PVR in the cases at one and three months post-OHT was not significantly different between the two groups. Only one of the cases required prolonged treatment with iloprost after OHT. Conclusions. A PVR above 6 WU should not be an absolute contraindication to heart transplantation in children.

18.
Am J Cardiol ; 104(4): 596-601, 2009 Aug 15.
Article in English | MEDLINE | ID: mdl-19660618

ABSTRACT

Heart donor candidates have severe neurologic injuries that have been associated with significant prolongation of the corrected QT (QTc) interval. Screening for an underlying abnormality of cardiac repolarization such as the long-QT syndrome thus becomes difficult. The aims of this study were to establish normal values and determine factors associated with prolongation of pre- and post-transplantation QTc intervals in a large cohort of heart transplantation donors and recipients. The medical records of 179 donors and 112 recipients were reviewed for historical, electrocardiographic, and neuroimaging data. After linear regression analysis, gunshot wounds were associated with the shortest mean pre-transplantation QTc interval of 447 +/- 51 ms (p = 0.016), whereas all other mechanisms of brain injury were associated with markedly prolonged QTc intervals. Overall, the mean QTc interval decreased from 467 +/- 58 to 446 +/- 47 ms (p <0.001), the mean QRS duration increased from 87 +/- 16 to 98 +/- 21 ms (p <0.001), and the mean QT dispersion did not change significantly after transplantation. The only factor associated with a prolonged QTc interval in the post-transplantation period was hypokalemia, with a mean QTc of 468 +/- 37 ms (p = 0.047). In conclusion, the mechanism of donor brain injury is associated with alterations in the pre-transplantation QTc interval, with the shortest intervals related to gunshot wounds. Fewer than 5% of the donor population was found to have QTc interval > or =580 ms. For those afflicted by gunshot wounds, <5% had QTc intervals > or =550 ms. This information can be used in pre-transplantation donor assessment, and post-transplantation management can be tailored to avoid the occurrence of ventricular arrhythmia.


Subject(s)
Brain Death/physiopathology , Brain Injuries/physiopathology , Heart Transplantation , Long QT Syndrome/physiopathology , Long QT Syndrome/surgery , Adolescent , Adult , Aged , Brain Injuries/etiology , Brain Injuries/pathology , Child , Child, Preschool , Cohort Studies , Electrocardiography , Humans , Infant , Long QT Syndrome/etiology , Middle Aged , Retrospective Studies , Tissue Donors , Young Adult
19.
Pediatr Transplant ; 13(7): 887-91, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19017288

ABSTRACT

The pathologic patterns existing in end-stage pediatric heart transplant grafts may help explain the symptoms and changes seen by echocardiography and angiography in these children. Retrospective chart review and pathologic study of explanted heart grafts was performed on 12 patients that had undergone 14 heart re-transplantations. Clinical status, echocardiographic and catheterization data at the time of transplantation were correlated to the pathologic findings. At re-OHT, eight were inpatients with heart failure symptoms and/or inotropic support requirements. Echocardiograms were abnormal in all prior to re-OHT with significant diastolic dysfunction, but LVEF >40% in all but one. There was significant epicardial fibrosis in all grafts, and all had severe CAV of epicardial arteries. However, intramyocardial coronary disease was mild in nine (64%) grafts. Moderate or severe interstitial fibrosis occurred in only three grafts, and in a perivascular distribution in eight. End-stage pediatric heart allografts have severe epicardial CAV and epicardial fibrosis, with relative sparing of the myocardium. Epicardial disease with sparing of the myocardium may explain the restrictive hemodynamics and relatively preserved systolic function present in these grafts at the time of re-OHT.


Subject(s)
Heart Transplantation/methods , Pediatrics/methods , Adolescent , Adult , Angiography/methods , Child , Echocardiography/methods , Female , Fibrosis/pathology , Heart Diseases/surgery , Heart Diseases/therapy , Heart Failure/surgery , Heart Failure/therapy , Humans , Male , Myocardium/pathology , Retrospective Studies
20.
Pediatr Transplant ; 12(4): 436-41, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18466430

ABSTRACT

This study evaluated changes in growth parameters after pediatric heart transplantation and identified factors associated with the changes after pediatric heart transplantation (OHT). We retrospectively evaluated the somatic growth of 46 children <11 yr of age who underwent OHT for changes in weight, height, and BMI. The patient age range was 3.5 months to 10.7 yr. Gain in Z score for weight and BMI was significant at six months post-OHT (mean weight Z score changed from -1.1 to -0.1 and mean BMI Z score changed from -0.1 to 1.3; p < 0.001). After six months post-OHT, there was no further significant change in weight or BMI Z score. Height Z score did not show significant change from pre-OHT at six months, one yr, or two yr post-OHT. Eight patients (17%) became overweight during the two-yr follow-up period as evidenced by a BMI Z score > 2. Multivariate analysis showed length of steroid treatment as a predictor for negative height Z score change, and age at transplant as a predictor for positive height Z score change. Post-OHT, weight significantly increases without proportional increases in height, resulting in a significant proportion of these children becoming obese. Length of steroid therapy is negatively related to the "catch-up" linear growth following OHT.


Subject(s)
Heart Transplantation/methods , Body Composition , Body Height , Body Mass Index , Body Weight , Child , Child, Preschool , Female , Follow-Up Studies , Growth , Growth Disorders/prevention & control , Humans , Infant , Male , Weight Gain
SELECTION OF CITATIONS
SEARCH DETAIL
...